Sign inJoin waitlistJoin the waitlist

LW

Luke Walker

Hematology & Oncology

Credentials: ·

Research

A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck…
Oral Oncology · 2015 · 68 citations
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic…
Journal of Thoracic Oncology · 2014 · 40 citations
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma
Clinical Colorectal Cancer · 2016 · 36 citations

AS
Alexander Spira
3 papers
Daniel Bowles
3 papers
DH
Diana Hausman
3 papers
ER
Evelyn Rustia
3 papers
IS
Ian Schnadig
3 papers
Antonio Jimeno
2 papers
BL
Benjamin Levy
2 papers · 1 as a fellow
Charles Rudin
2 papers
Julie Bauman
2 papers
AC
Allen Cohn
1 paper
AU
Antonio Ucar
1 paper
AC
Arvind Chaudhry
1 paper